Aristides Capital LLC Sells 18,143 Shares of Genpact Limited $G

Key Points

• Aristides Capital LLC reduced its stake in Genpact Limited by 22.1%, now holding 63,990 shares valued at approximately $3.22 million.
• Genpact reported an earnings per share (EPS) of $0.88 for the last quarter, surpassing the consensus estimate of $0.85, alongside a revenue of $1.25 billion.
• The company announced a quarterly dividend of $0.17, equating to an annualized yield of 1.5%, with the ex-dividend date set for September 11th.

Aristides Capital LLC lessened its stake in shares of Genpact Limited (NYSE:G - Free Report) by 22.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 63,990 shares of the business services provider's stock after selling 18,143 shares during the period. Genpact accounts for approximately 1.0% of Aristides Capital LLC's investment portfolio, making the stock its 21st biggest position. Aristides Capital LLC's holdings in Genpact were worth $3,224,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SVB Wealth LLC acquired a new position in Genpact during the first quarter worth about $41,000. Smartleaf Asset Management LLC lifted its stake in shares of Genpact by 40.8% in the 1st quarter. Smartleaf Asset Management LLC now owns 1,367 shares of the business services provider's stock valued at $68,000 after purchasing an additional 396 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of Genpact by 109.8% during the first quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider's stock valued at $81,375,000 after acquiring an additional 845,393 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Genpact by 421.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 767,386 shares of the business services provider's stock worth $38,662,000 after purchasing an additional 620,201 shares during the period. Finally, Credit Agricole S A acquired a new stake in shares of Genpact in the first quarter valued at $1,843,000. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Trading Down 0.9%

Genpact stock traded down $0.43 during midday trading on Thursday, reaching $44.98. The stock had a trading volume of 1,510,683 shares, compared to its average volume of 2,134,289. The firm's fifty day simple moving average is $44.25 and its two-hundred day simple moving average is $46.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. Genpact Limited has a twelve month low of $37.82 and a twelve month high of $56.76. The firm has a market cap of $7.84 billion, a price-to-earnings ratio of 14.94, a PEG ratio of 1.56 and a beta of 0.92.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the previous year, the firm earned $0.79 earnings per share. Genpact's quarterly revenue was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Equities analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.5%. Genpact's dividend payout ratio (DPR) is 22.59%.

Wall Street Analysts Forecast Growth

G has been the subject of several recent research reports. Mizuho raised their price target on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research report on Tuesday, July 1st. Robert W. Baird dropped their price objective on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Deutsche Bank Aktiengesellschaft began coverage on Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price on the stock. Finally, Needham & Company LLC raised their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Genpact has an average rating of "Hold" and an average target price of $52.29.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.